Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo A Toledo

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Nature Reviews. Endocrinology|June 3, 2018
Inflated pathogenic variant profiles in the ClinVar databaseRodrigo A Toledo,
Nature Reviews. Endocrinology|September 11, 2025
FDA fast-track approval of belzutifan is a milestone in rare cancer therapyCarlota Arenillas, Rodrigo A Toledo
Clinical Endocrinology|October 31, 2013
Next-generation sequencing for the genetic screening of phaeochromcytomas and paragangliomas: riding the new wave, but with cautionRodrigo A Toledo, Patricia L M Dahia
Nature Reviews. Endocrinology|February 13, 2020
Recognizing hypoxia in phaeochromocytomas and paragangliomasPatricia L M Dahia, Rodrigo A Toledo
Current Opinion in Endocrinology, Diabetes, and Obesity|April 15, 2015
Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromesRodrigo A Toledo, Patricia L M Dahia
Clinics (Sao Paulo, Brazil)|August 7, 2013
A differential diagnosis of inherited endocrine tumors and their tumor counterpartsSergio P A Toledo, Delmar M Lourenço, Rodrigo A Toledo
Frontiers of Hormone Research|July 10, 2010
Familial isolated pituitary adenoma: evidence for genetic heterogeneityRodrigo A Toledo, Delmar M Lourenço, Sergio P A Toledo
Endocrine Reviews|October 27, 2022
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor HypoxiaRodrigo A Toledo, Camilo Jimenez, Gustavo Armaiz-Pena, et al.
Clinics (Sao Paulo, Brazil)|May 16, 2012
Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1Flavia L Coutinho, Delmar M Lourenco, Rodrigo A Toledo, et al.
Clinics (Sao Paulo, Brazil)|May 16, 2012
Narrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in BrazilRodrigo A Toledo, Tomoko Sekiya, Viviane C Longuini, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Nature Reviews. Endocrinology|June 3, 2018
Inflated pathogenic variant profiles in the ClinVar databaseRodrigo A Toledo,
Nature Reviews. Endocrinology|September 11, 2025
FDA fast-track approval of belzutifan is a milestone in rare cancer therapyCarlota Arenillas, Rodrigo A Toledo
Clinical Endocrinology|October 31, 2013
Next-generation sequencing for the genetic screening of phaeochromcytomas and paragangliomas: riding the new wave, but with cautionRodrigo A Toledo, Patricia L M Dahia
Nature Reviews. Endocrinology|February 13, 2020
Recognizing hypoxia in phaeochromocytomas and paragangliomasPatricia L M Dahia, Rodrigo A Toledo
Current Opinion in Endocrinology, Diabetes, and Obesity|April 15, 2015
Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromesRodrigo A Toledo, Patricia L M Dahia
Clinics (Sao Paulo, Brazil)|August 7, 2013
A differential diagnosis of inherited endocrine tumors and their tumor counterpartsSergio P A Toledo, Delmar M Lourenço, Rodrigo A Toledo
Frontiers of Hormone Research|July 10, 2010
Familial isolated pituitary adenoma: evidence for genetic heterogeneityRodrigo A Toledo, Delmar M Lourenço, Sergio P A Toledo
Endocrine Reviews|October 27, 2022
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor HypoxiaRodrigo A Toledo, Camilo Jimenez, Gustavo Armaiz-Pena, et al.
Clinics (Sao Paulo, Brazil)|May 16, 2012
Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1Flavia L Coutinho, Delmar M Lourenco, Rodrigo A Toledo, et al.
Clinics (Sao Paulo, Brazil)|May 16, 2012
Narrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in BrazilRodrigo A Toledo, Tomoko Sekiya, Viviane C Longuini, et al.
Pageof 7